0001209191-23-002778.txt : 20230110
0001209191-23-002778.hdr.sgml : 20230110
20230110161825
ACCESSION NUMBER: 0001209191-23-002778
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230106
FILED AS OF DATE: 20230110
DATE AS OF CHANGE: 20230110
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allison David D.
CENTRAL INDEX KEY: 0001853903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41201
FILM NUMBER: 23521362
MAIL ADDRESS:
STREET 1: C/O IMPEL NEUROPHARMA, INC.
STREET 2: 201 ELLIOTT AVE. W, ST. 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CinCor Pharma, Inc.
CENTRAL INDEX KEY: 0001868734
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 THIRD AVE., 6TH FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 8445311834
MAIL ADDRESS:
STREET 1: 230 THIRD AVE., 6TH FLOOR
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-06
0
0001868734
CinCor Pharma, Inc.
CINC
0001853903
Allison David D.
C/O CINCOR PHARMA, INC.
230 THIRD AVENUE, 6TH FLOOR
WALTHAM
MA
02451
1
0
0
0
Stock Option (Right to Buy)
11.78
2023-01-06
4
A
0
1499
8.34
A
2023-01-06
2033-01-05
Common Stock
1499
1499
D
This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $12,500.
/s/ Cathy Rude, Attorney-in-Fact
2023-01-10